Antidiabetic Activity of a Flavonoid-Rich Extract From

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

21 citing papers in PubMed, 55 citations in OpenAlex.

1. Therapeutic Potential of Flavonoids in Diabetes Mellitus Management: Molecular Insights and the Future Directions for Drug Design.Current drug discovery technologies · 2026
   Review
2. The Effect and Mechanism of Regular Exercise on Improving Insulin Impedance: Based on the Perspective of Cellular and Molecular Levels.International journal of molecular sciences · 2025
   Review
3. Evaluation of the Hypoglycemic and Hypolipidemic Potential of Extract Fraction ofCurrent pharmaceutical design · 2024
   Article
4. Maackiain Mimics Caloric Restriction throughInternational journal of molecular sciences · 2023
   Article
5. Bioactivity and mechanisms of flavonoids in decreasing insulin resistance.Journal of enzyme inhibition and medicinal chemistry · 2023
   Review
6. Triterpenoid saponins and CRSC advances · 2023
   Article
7. Glucose Uptake Is Increased by Estradiol Dipropionate in L6 Skeletal Muscle Cells.Pharmaceuticals (Basel, Switzerland) · 2022
   Article
8. Protective Roles of Apigenin Against Cardiometabolic Diseases: A Systematic Review.Frontiers in nutrition · 2022
   Review
9. Frontiers in nutrition · 2022
   Article
10. The complete chloroplast genome ofMitochondrial DNA. Part B, Resources · 2022
    Article
11. Genus Sophora: a comprehensive review on secondary chemical metabolites and their biological aspects from past achievements to future perspectives.Archives of pharmacal research · 2021
    Review
12. Davidones F and G, Two Novel Flavonoids fromMolecules (Basel, Switzerland) · 2021
    Article
13. Chemical Constituents from Roots ofMolecules (Basel, Switzerland) · 2021
    Article
14. Antioxidant Effects ofFrontiers in pharmacology · 2021
    Article
15. Maackiain Protects the Kidneys of Type 2 Diabetic Rats via Modulating the Nrf2/HO-1 and TLR4/NF-κB/Caspase-3 Pathways.Drug design, development and therapy · 2021
    Article
16. An Insight into Phytochemical, Pharmacological, and Nutritional Properties ofEvidence-based complementary and alternative medicine : eCAM · 2021
    Review
17. Maackiain Ameliorates 6-Hydroxydopamine andInternational journal of molecular sciences · 2020
    Article
18. Medium- and long-chain triglyceride propofol reduces the activity of acetyl-coenzyme A carboxylase in hepatic lipid metabolism in HepG2 and Huh7 cells.The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology · 2020
    Article
19. QiDiTangShen Granules Activate Renal Nutrient-Sensing Associated Autophagy in db/db Mice.Frontiers in physiology · 2019
    Article
20. Neferine Promotes GLUT4 Expression and Fusion With the Plasma Membrane to Induce Glucose Uptake in L6 Cells.Frontiers in pharmacology · 2019
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

8 authors at 2 institutions in 1 country.

Funding

No grant is acknowledged in the PubMed record.

Abstract

Indexed as